BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29066479)

  • 1. Eosinophil Cationic Protein in Patients with Differentiated Thyroid Cancer Treated with Radioactive Iodine 131.
    Zivancevic-Simonovic S; Mihaljevic O; Kostic I; Ilic N; Mihajlovic D; Vasiljevic D; Mijatovic-Teodorovic L; Miletic-Drakulic S; Colic M
    Ann Clin Lab Sci; 2017 Sep; 47(5):541-545. PubMed ID: 29066479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy.
    Simonovic SZ; Mihaljevic O; Majstorovic I; Djurdjevic P; Kostic I; Djordjevic OM; Teodorovic LM
    Cancer Immunol Immunother; 2015 Jan; 64(1):75-82. PubMed ID: 25297452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive papillary carcinoma of the thyroid gland treated by external beam radiotherapy, surgery and postoperative radioactive iodine therapy.
    Naveed A; Kanaan F; Tjernstrom NO
    Eur Arch Otorhinolaryngol; 2009 Nov; 266(11):1837-9. PubMed ID: 19294401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
    Nakanishi K; Kikumori T; Miyajima N; Takano Y; Noda S; Takeuchi D; Iwano S; Kodera Y
    Clin Nucl Med; 2018 Jul; 43(7):482-485. PubMed ID: 29688947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of differentiated carcinoma of the thyroid gland].
    Mimura T; Ito K
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1184-9. PubMed ID: 9379097
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
    Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
    Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
    Sacks W; Wong RM; Bresee C; Braunstein GD
    Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation.
    Oltmann SC; Schneider DF; Leverson G; Sivashanmugam T; Chen H; Sippel RS
    Ann Surg Oncol; 2014 Apr; 21(4):1379-83. PubMed ID: 24378987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
    Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
    Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
    Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
    Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
    Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan.
    Ansari M; Babaei AA; Shafiei B; Javadi H; Assadi M; Nabipour I; Asli IN
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1925-9. PubMed ID: 25010624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatment.
    Guy A; Hirsch D; Shohat T; Bachar G; Tirosh A; Robenshtok E; Shimon I; Benbassat CA
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4167-73. PubMed ID: 25157544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative radioactive iodine-131 ablation is not necessary among patients with intermediate-risk differentiated thyroid carcinoma: a population-based study.
    Zhang H; Cai Y; Zheng L; Zhang Z; Jiang N
    Hell J Nucl Med; 2017; 20(1):3-10. PubMed ID: 28315902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to and treatment of differentiated thyroid carcinoma.
    Pacini F; Castagna MG
    Med Clin North Am; 2012 Mar; 96(2):369-83. PubMed ID: 22443981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.
    Lubitz CC; De Gregorio L; Fingeret AL; Economopoulos KP; Termezawi D; Hassan M; Parangi S; Stephen AE; Halpern EF; Donelan K; Swan JS
    Thyroid; 2017 Feb; 27(2):197-206. PubMed ID: 27824301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.
    Kuo HC; Wang CL; Liang CD; Yu HR; Huang CF; Wang L; Hwang KP; Yang KD
    Pediatr Allergy Immunol; 2009 May; 20(3):266-72. PubMed ID: 19438983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Impact of BMI on the Aggressiveness of Presentation and Clinical Outcome of Differentiated Thyroid Cancer.
    Matrone A; Ceccarini G; Beghini M; Ferrari F; Gambale C; D'Aqui M; Piaggi P; Torregrossa L; Molinaro E; Basolo F; Vitti P; Santini F; Elisei R
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31875910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
    Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
    Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.